Screener
BioLife Solutions BLFS Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation | 785 | 1,356 |
| Amortization of intangible assets | 723 | 1,410 |
| Stock-based compensation | 8,660 | 10,012 |
| Non-cash lease expense | 1,661 | 670 |
| Deferred income tax (benefit) expense | (42,422) | 51 |
| Accretion of available-for-sale investments | (197) | (305) |
| Gain on disposal of assets held for rent, net | — | 343 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's stock-based comp?
- BioLife Solutions (BLFS) reported stock-based comp of $3.85M in Q2 2026.
- How has BioLife Solutions's stock-based comp changed year-over-year?
- BioLife Solutions's stock-based comp decreased by 34.2% year-over-year, from $5.86M to $3.85M.
- What is the long-term trend for BioLife Solutions's stock-based comp?
- Over 4 years (2021 to 2025), BioLife Solutions's stock-based comp has grown at a 13.3% compound annual growth rate (CAGR), from $13.96M to $22.99M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about BioLife Solutions's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude